June 7 Event Addresses Impact of Traffic Exhaust on Children s Health
CINCINNATIJoin Cincinnati City Council members, public policy makers, local childrens health experts and transportation officials to discuss how Cincinnati traffic affects childrens health, air quality standards, current transportation plans and other topics.
Free and open to the public, the "Impact of Traffic Exhaust on Childrens Health: Transportation Symposium for the Greater Cincinnati Region event takes place June 7, 2012, from 1 to 3:30 p.m. at OKI (Ohio-Kentucky-Indiana Regional Council of Governments), located at 720 E. Pete Rose Way in downtown Cincinnati.
Speakers and panelists include (in order of agenda):
- Michael Moore, Director of Transportation and Engineering, City of Cincinnati
- Cory Chadwick, Director of Hamilton County Department of Environmental Services
- Patrick Ryan, PhD, Assistant Professor, UC College of Medicine and Cincinnati Childrens Hospital Medical Center Researcher
- Robert Koehler, Deputy Executive Director of Transportation, OKI The Ohio-Kentucky-Indiana Regional Council of Governments
- Grace LeMasters, PhD, Professor, UC College of Medicine Department of Environmental Health
- Erin Haynes, DrPH, UC College of Medicine Department of Environmental Health
- Camille Jones, MD, City of Cincinnati Assistant Health Commissioner
City of Cincinnati Councilmembers Laure Quinlivan, Yvette Simpson and Chris Seelbach will also participate in the symposium.
Complimentary refreshments will be provided by Fuel Coffee Cincinnati. RSVPs are requested by contacting Sarah Elam at sarah.elam@uc.edu or 513-558-2149. Free parking is also available at Sawyer Point.
Sponsors include the University of Cincinnatis Community Outreach and Engagement Core and Center for Environmental Genetics, Green Umbrella, OKI, Hamilton County Environmental Services and the City of Cincinnati Office of Environmental Quality.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.